Cardlytics (CDLX) PT Raised to $75 at SunTrust
SunTrust analyst Youssef Squali raised the price target on Cardlytics (NASDAQ: CDLX) to $75.00 (from $55.00) while maintaining a Buy rating.
You May Also Be Interested In
- UPDATE: Morgan Stanley Upgrades Sony Corp. (6758:JP) (SNE) to Overweight
- Dr. Reddy\'s Laboratories Ltd. (DRRD:IN) (RDY) PT Lowered to Rs5,110 at Goldman Sachs, Following Earnings
- Boston Scientific (BSX) PT Raised to $53 at Cowen
Create E-mail Alert Related CategoriesAnalyst PT Change
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!